01890nam 2200433 450 991071295270332120200306110050.0(CKB)5470000002498666(OCoLC)1143391364(EXLCZ)99547000000249866620200306d2018 ua 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierDrug discount program: improvements needed in federal oversight of compliance at 340B contract pharmacies testimony before the Subcommittee on Health, Committee, Energy and Commerce, House of Representatives // statement of Debra A. Draper[Washington, D.C.] :United States Government Accountability Office,2018.1 online resource (9 pages)Testimony ;GAO-18-646T"For release on delivery, expected at 10:00 a.m. ET, Wednesday, July 11, 2018."Includes bibliographical references.Drug discount programPrescription pricingLaw and legislationUnited StatesDrug accessibilityLaw and legislationUnited StatesDrugsPricesLaw and legislationUnited StatesPoorPharmaceutical assistanceUnited StatesPrescription pricingLaw and legislationDrug accessibilityLaw and legislationDrugsPricesLaw and legislationPoorPharmaceutical assistanceDraper DebraUnited States.Congress.House.Committee on Energy and Commerce.Subcommittee on Health,GPOGPOBOOK9910712952703321Drug discount program: improvements needed in federal oversight of compliance at 340B contract pharmacies3462210UNINA